Inappropriate Use of Psychotropic Drugs in Older Individuals: Implications for Practice

• Stafford AC , TenniPC, PetersonGMet al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm. World Sci. 31(2), 216–223(2009).
   PubMedGoogle Scholar
• Somers A . Detection and Prevention of Drug Related Problems in Older Hospitalized Patients – the Challenge for the Clinical Pharmacist. Ghent University, Ghent, Belgium (2012).
   Google Scholar
• Hanlon JT , FillenbaumGG, SchmaderKEet al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 20(5), 575–582(2000).
   PubMed Web of Science ®Google Scholar
• Golden AG , PrestonRA, BarnettSDet al. Inappropriate medication prescribing in homebound older adults. J. Am. Geriatr. Soc. 47(8), 948–953(1999).
   PubMed Web of Science ®Google Scholar
• Piecoro LT , BrowningSR, PrinceTS, RanzTT, ScutchfieldFD. A database analysis of potentially inappropriate drug use in an elderly medicaid population. Pharmacotherapy20(2), 221–228(2000).
   PubMed Web of Science ®Google Scholar
• Mort JR , AparasuRR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs16(2), 99–109(2002).
   PubMed Web of Science ®Google Scholar
• Cooper JW . Reducing falls among patients in nursing homes. JAMA278(21), 1742 (1997).
   PubMedGoogle Scholar
• Cooper JW . Reducing psychotropic drugs reduces falls in elderly people. BMJ323(7309), 402 (2001).
   PubMedGoogle Scholar
• NSW Department of Health. Psychotropic Medication Use in Nursing Homes: Report of the NSW Ministerial Taskforce. Department of Health, New South Wales, Australia (1997).
   Google Scholar
• Sunderland T . Neurotransmission in the aging central nervous system. In: Clinical Geriatric Psychopharmacology (4th Edition). Lipincott Williams & Wilkins, PA, USA, 64–85(2005).
   Google Scholar
• Azermai M . Psychotropic Drug Use in Older Persons: a Focus on Antipsychotics for Behavioural and Psychological Symptoms of Dementia. Ghent University, Ghent, Belgium (2012).
   Google Scholar
• von Moltke L , AbernethyD, GreenblattD. Kinetics and dynamics of psychotropic drugs in the elderly. In: Clinical Geriatric Psychopharmacology (4th Edition). Lippincott Williams & Wilkins, PA, USA, 87–114(2005).
   Google Scholar
• Pedigo NW Jr. Neurotransmitter receptor plasticity in aging. Life Sci.55(25–26), 1985–1991(1994).
   PubMed Web of Science ®Google Scholar
• Vander S tichele, Van de Voorde C, Elseviers MM et al.Medication use in Belgian rest and nursing homes. KCE Reports 47A. Belgian Health Care Knowledge Centre, Brussels, Belgium (2006).
   Google Scholar
• Mort JR , AparasuRR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs16(2), 99–109(2002).
   PubMed Web of Science ®Google Scholar
• Azermai M , ElseviersM, PetrovicM, Van Bortel L, Vander Stichele R. Geriatric drug utilisation of psychotropics in Belgian nursing homes. Hum. Psychopharmacol.26(1), 12–20(2011).
   PubMed Web of Science ®Google Scholar
• Wancata J , BendaN, MeiseU, MullerC. Psychotropic drug intake in residents newly admitted to nursing homes. Psychopharmacology (Berl.)134(2), 115–120(1997).
   PubMed Web of Science ®Google Scholar
• Bronskill SE , AndersonGM, SykoraKet al. Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact. J. Am. Geriatr. Soc. 52(5), 749–755(2004).
   PubMed Web of Science ®Google Scholar
• Glick ID , MurraySR, VasudevanP, MarderSR, HuRJ. Treatment with atypical antipsychotics: new indications and new populations. J. Psychiatr. Res.35(3), 187–191(2001).
   PubMed Web of Science ®Google Scholar
• Ballard C , HowardR. Neuroleptic drugs in dementia: benefits and harm. Nat. Rev. Neurosci.7(6), 492–500(2006).
   PubMed Web of Science ®Google Scholar
• Mann E , KopkeS, HaastertB, PitkalaK, MeyerG. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr.9, 18 (2009).
   PubMedGoogle Scholar
• Kamble P , ChenH, ShererJ, AparasuRR. Antipsychotic drug use among elderly nursing home residents in the United States. Am. J. Geriatr. Pharmacother.6(4), 187–197(2008).
   PubMed Web of Science ®Google Scholar
• Testad I , AuerS, MittelmanMet al. Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. Int. J. Geriatr. Psychiatry 25(7), 725–731(2010).
   PubMed Web of Science ®Google Scholar
• Petrovic M , HurtC, CollinsDet al. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer‘s disease consortium (EADC) study. Acta Clin. Belg. 62(6), 426–432(2007).
   PubMed Web of Science ®Google Scholar
• Stoppe G , BrandtCA, StaedtJH. Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging14(1), 41–54(1999).
   PubMed Web of Science ®Google Scholar
• Yaffe K , FoxP, NewcomerRet al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 287(16), 2090–2097(2002).
   PubMed Web of Science ®Google Scholar
• Azermai M , ElseviersM, PetrovicM, van Bortel L, Stichele RV. Assessment of antipsychotic prescribing in Belgian nursing homes. Int. Psychogeriatr.23(8), 1240–1258(2011).
   PubMed Web of Science ®Google Scholar
• Schneider LS , DagermanK, InselPS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am. J. Geriatr. Psychiatry14(3), 191–210(2006).
   PubMed Web of Science ®Google Scholar
• Ballard C , WaiteJ. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer‘s disease. Cochrane Database Syst. Rev.1, CD003476 (2006).
   PubMedGoogle Scholar
• Schneider LS , TariotPN, DagermanKSet al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer‘s disease. N. Engl. J. Med. 355(15), 1525–1538(2006).
   PubMed Web of Science ®Google Scholar
• Sultzer DL , DavisSM, TariotPNet al. Clinical symptom responses to atypical antipsychotic medications in Alzheimer‘s disease: Phase 1 outcomes from the CATIE-AD effectiveness trial. Am. J. Psychiatry 165(7), 844–854(2008).
   PubMed Web of Science ®Google Scholar
• Trifiro G , SpinaE, GambassiG. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile? Pharmacol. Res.59(1), 1–12(2009).
   PubMed Web of Science ®Google Scholar
• Banerjee S . The Use of Antipsychotic Medication for People with Dementia: Time for Action. A Report for the Minister of State for Care Services. Department of Health, London, UK (2009).
   Google Scholar
• Ashton H . Guidelines for the rational use of benzodiazepines. When and what to use. Drugs48(1), 25–40(1994).
   PubMed Web of Science ®Google Scholar
• Neutel CI . The epidemiology of long-term benzodiazepine use. Int. Rev. Psychiatry17(3), 189–197(2005).
   PubMed Web of Science ®Google Scholar
• Bourgeois J , ElseviersMM, AzermaiMet al. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages. Eur. J. Clin. Pharmacol. 68(5), 833–844(2012).
   PubMed Web of Science ®Google Scholar
• McIntosh B , ClarkM, SpryC. Benzodiazepines in Older Adults: a Review of Clinical Effectiveness, Cost–Effectiveness, and Guidelines. Canadian Agency for Drugs and Technologies in Health, Ottowa, ON, Canada (2010).
   Google Scholar
• Martin JL , Sainz-PardoM, FurukawaTAet al. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol. 21(7), 774–782(2007).
   PubMed Web of Science ®Google Scholar
• Lader M , TyleeA, DonoghueJ. Withdrawing benzodiazepines in primary care. CNS Drugs23(1), 19–34(2009).
   PubMed Web of Science ®Google Scholar
• Verdoux H , LagnaouiR, BegaudB. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol. Med.35(3), 307–315(2005).
   PubMed Web of Science ®Google Scholar
• Gray SL , LaCroixAZ, HanlonJTet al. Benzodiazepine use and physical disability in community-dwelling older adults. J. Am. Geriatr. Soc. 54(2), 224–230(2006).
   PubMed Web of Science ®Google Scholar
• Fourrier A , LetenneurL, DartiguesJF, MooreN, BegaudB. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur. J. Clin. Pharmacol.57(5), 419–425(2001).
   PubMed Web of Science ®Google Scholar
• Petrovic M , MarimanA, WarieH, AfschriftM, PevernagieD. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin. Belg.58(1), 27–36(2003).
   PubMed Web of Science ®Google Scholar
• Wu CS , WangSC, ChangIS, LinKM. The association between dementia and long-term use of benzodiazepine in the elderly: nested case–control study using claims data. Am. J. Geriatr. Psychiatry17(7), 614–620(2009).
   PubMed Web of Science ®Google Scholar
• Madhusoodanan S , BogunovicOJ. Safety of benzodiazepines in the geriatric population. Expert Opin. Drug Saf.3(5), 485–493(2004).
   PubMedGoogle Scholar
• Stevenson DG , DeckerSL, DwyerLLet al. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am. J. Geriatr. Psychiatry 18(12), 1078–1092(2010).
   PubMed Web of Science ®Google Scholar
• Dijk DJ , GroegerJA, StanleyN, DeaconS. Age-related reduction in daytime sleep propensity and nocturnal slow wave sleep. Sleep33(2), 211–223(2010).
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S . Sleep and aging: prevalence of disturbed sleep and treatment considerations in older adults. J. Clin. Psychiatry66(Suppl. 9), S24–S30 (2005).
   PubMed Web of Science ®Google Scholar
• Somers A , RobaysH, AudenaertKet al. The use of hypnosedative drugs in a university hospital: has anything changed in 10 years? Eur. J. Clin. Pharmacol. 67(7), 723–729(2011).
   PubMed Web of Science ®Google Scholar
• Kramer D , AllgaierAK, FejtkovaS, MerglR, HegerlU. Depression in nursing homes: prevalence, recognition, and treatment. Int. J. Psychiatry Med.39(4), 345–358(2009).
   PubMed Web of Science ®Google Scholar
• Achterberg W , PotAM, KerkstraA, RibbeM. Depressive symptoms in newly admitted nursing home residents. Int. J. Geriatr. Psychiatry21(12), 1156–1162(2006).
   PubMed Web of Science ®Google Scholar
• Bourgeois J , ElseviersMM, Van Bortel L, Petrovic M, Vander Stichele RH. The use of antidepressants in belgian nursing homes: focus on indications and dosages in the PHEBE study. Drugs Aging29(9), 759–769(2012).
   PubMed Web of Science ®Google Scholar
• Beekman AT , CopelandJR, PrinceMJ. Review of community prevalence of depression in later life. Br. J. Psychiatry174, 307–311(1999).
   PubMed Web of Science ®Google Scholar
• Gaboda D , LucasJ, SiegelM, KalayE, CrystalS. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. J. Am. Geriatr. Soc.59(4), 673–680(2011).
   PubMed Web of Science ®Google Scholar
• Hanlon JT , HandlerSM, CastleNG. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J. Am. Med. Dir. Assoc.11(5), 320–324(2010).
   PubMed Web of Science ®Google Scholar
• Karkare SU , BhattacharjeeS, KambleP, AparasuR. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am. J. Geriatr. Pharmacother.9(2), 109–119(2011).
   PubMedGoogle Scholar
• Hoover DR , SiegelM, LucasJet al. Depression in the first year of stay for elderly long-term nursing home residents in the USA. Int. Psychogeriatr. 22(7), 1161–1171(2010).
   PubMed Web of Science ®Google Scholar
• Schneider LS , OlinJT. Efficacy of acute treatment for geriatric depression. Int. Psychogeriatr.7(Suppl.), S7–S25 (1995).
   PubMedGoogle Scholar
• Hollon SD , JarrettRB, NierenbergAA, ThaseME, TrivediM, RushAJ. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment? J. Clin. Psychiatry66(4), 455–468(2005).
   PubMed Web of Science ®Google Scholar
• Roth AJ , McCallWV, LiguoriA. Cognitive, psychomotor and polysomnographic effects of trazodone in primary insomniacs. J. Sleep Res.20(4), 552–558(2011).
   PubMed Web of Science ®Google Scholar
• Mottram P , WilsonK, StroblJ. Antidepressants for depressed elderly. Cochrane Database Syst. Rev.1, CD003491 (2006).
   PubMedGoogle Scholar
• Petrovic M , De Paepe P, Van Bortel L. Pharmacotherapy of depression in old age. Acta Clin. Belg.60(3), 150–156(2005).
   PubMed Web of Science ®Google Scholar
• Movig KL , LeufkensHG, LenderinkAW, EgbertsAC. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur. J. Clin. Pharmacol.58(2), 143–148(2002).
   PubMed Web of Science ®Google Scholar
• Andrade C , SandarshS, ChethanKB, NageshKS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J. Clin. Psychiatry71(12), 1565–1575(2010).
   PubMed Web of Science ®Google Scholar
• Draper B , BermanK. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging25(6), 501–519(2008).
   PubMed Web of Science ®Google Scholar
• Hawton K , BergenH, SimkinSet al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br. J. Psychiatry 196(5), 354–358(2010).
   PubMed Web of Science ®Google Scholar
• Vestergaard P . Skeletal effects of central nervous system active drugs: anxiolytics, sedatives, antidepressants, lithium and neuroleptics. Curr. Drug Saf.3(3), 185–189(2008).
   PubMedGoogle Scholar
• Azermai M , PetrovicM, ElseviersMMet al. Systematic appraisal of dementia guidelines for the management of behavioural and psychological symptoms. Ageing Res. Rev. 11(1), 78–86(2012).
   PubMed Web of Science ®Google Scholar
• Opie J , RosewarneR, O‘ConnorDW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Aust. NZ J. Psychiatry33(6), 789–799(1999).
   PubMed Web of Science ®Google Scholar
• Kverno KS , BlackBS, NolanMT, RabinsPV. Research on treating neuropsychiatric symptoms of advanced dementia with non-pharmacological strategies, 1998–2008: a systematic literature review. Int. Psychogeriatr.21(5), 825–843(2009).
   PubMed Web of Science ®Google Scholar
• Cody M , BeckC, SvarstadBL. Challenges to the use of nonpharmacologic interventions in nursing homes. Psychiatr. Serv.53(11), 1402–1406(2002).
   PubMed Web of Science ®Google Scholar
• Volicer L , BassEA, LutherSL. Agitation and resistiveness to care are two separate behavioral syndromes of dementia. J. Am. Med. Dir. Assoc.8(8), 527–532(2007).
   PubMed Web of Science ®Google Scholar
• Blozik E , BornAM, StuckAEet al. Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study. Drugs Aging 27(12), 1009–1017(2010).
   PubMed Web of Science ®Google Scholar
• Chouinard G , ChouinardVA. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother. Psychosom.77(2), 69–77(2008).
   PubMed Web of Science ®Google Scholar
• Chouinard G , BradwejnJ, AnnableL, JonesBD, Ross-ChouinardA. Withdrawal symptoms after long-term treatment with low-potency neuroleptics. J. Clin. Psychiatry45(12), 500–502(1984).
   PubMed Web of Science ®Google Scholar
• Kales A , ScharfMB, KalesJD. Rebound insomnia: a new clinical syndrome. Science201(4360), 1039–1041(1978).
   PubMed Web of Science ®Google Scholar
• Fontaine R , ChouinardG, AnnableL. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am. J Psychiatry141(7), 848–852(1984).
   PubMed Web of Science ®Google Scholar
• Bhanji NH , ChouinardG, KolivakisT, MargoleseHC. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena. Can. J. Clin. Pharmacol.13(1), e69–e74 (2006).
   PubMedGoogle Scholar
• Chouinard G , JonesBD, AnnableL. Neuroleptic-induced supersensitivity psychosis. Am. J. Psychiatry135(11), 1409–1410(1978).
   PubMed Web of Science ®Google Scholar
• Chouinard G , JonesBD. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. Am. J. Psychiatry137(1), 16–21(1980).
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield J , LipsonS, WernerP, BilligN, TaylorL, WoosleyR. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch. Intern. Med.159(15), 1733–1740(1999).
   PubMedGoogle Scholar
• Devanand DP , PeltonGH, CunqueiroK, SackeimHA, MarderK. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer‘s disease. Int. J. Geriatr. Psychiatry26(9), 937–943(2011).
   PubMed Web of Science ®Google Scholar
• Ballard C , LanaMM, TheodoulouMet al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 5(4), e76 (2008).
   PubMed Web of Science ®Google Scholar
• Azermai M , PetrovicM, EngelborghsSet al. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study. Aging Ment. Health 17(1), 125–132(2013).
   PubMed Web of Science ®Google Scholar
• Ruths S , StraandJ, NygaardHA, AarslandD. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study – the Bergen District Nursing Home Study (BEDNURS). Int. J. Geriatr. Psychiatry23(9), 889–895(2008).
   PubMed Web of Science ®Google Scholar
• Petrovic M . Use and Discontinuation of Hypno-Sedative Medications in Geriatric Inpatients. Ghent University, Ghent, Belgium (2002).
   Google Scholar
• Petrovic M , PevernagieD, MarimanA, Van Maele G, Afschrift M. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial. Eur. J. Clin. Pharmacol.57(11), 759–764(2002).
   PubMed Web of Science ®Google Scholar
• Bogetto F , BellinoS, RevelloRB, PatriaL. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation. CNS Drugs16(4), 273–283(2002).
   PubMedGoogle Scholar
• Bostick JE , RantzMJ, FlesnerMK, RiggsCJ. Systematic review of studies of staffing and quality in nursing homes. J. Am. Med. Dir. Assoc.7(6), 366–376(2006).
   PubMed Web of Science ®Google Scholar
• van de Ven G , DraskovicI, AdangEMet al. Improving person-centred care in nursing homes through dementia-care mapping: design of a cluster-randomised controlled trial. BMC Geriatr. 12, 1 (2012).
   PubMed Web of Science ®Google Scholar

Websites

• US FDA Public Health Advisory. Deaths with antipsychotics in elderly patients with behavioral disturbances. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/UCM053171
   Google Scholar
• US FDA Public Health Advisory. Antipsychotics are not indicated for the treatment of dementia-related psychosis. www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm
   Google Scholar
• EMA. Public statement on the safety of olanzapine (2004). www.bfarm.de/SharedDocs/1_Downloads/DE/Pharmakovigilanz/am-sicher-akt/emea-zyprexa-st.pdf?__blob=publicationFile
   Google Scholar
• NICE. Generalized anxiety disorder and panic disorder (with or without agoraphobia) in adults. www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf
   Google Scholar
• NICE. The treatment and management of depression in adults. www.nice.org.uk/CG90
   Google Scholar
• Pulse. GPs will face penalties for prescribing antipsychotics to patients with dementia. www.pulsetoday.co.uk/newsarticle-content/-/article_display_list/13399564/gps-will-face-penalties-for-prescribing-antipsychotics-to-patients-with-dementia
   Google Scholar